SG10202002556QA - Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere - Google Patents
Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomereInfo
- Publication number
- SG10202002556QA SG10202002556QA SG10202002556QA SG10202002556QA SG10202002556QA SG 10202002556Q A SG10202002556Q A SG 10202002556QA SG 10202002556Q A SG10202002556Q A SG 10202002556QA SG 10202002556Q A SG10202002556Q A SG 10202002556QA SG 10202002556Q A SG10202002556Q A SG 10202002556QA
- Authority
- SG
- Singapore
- Prior art keywords
- ribonucleoside analogues
- mercaptopurine ribonucleoside
- altering
- mediated telomere
- telomerase mediated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361809575P | 2013-04-08 | 2013-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202002556QA true SG10202002556QA (en) | 2020-04-29 |
Family
ID=50819958
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201508336TA SG11201508336TA (en) | 2013-04-08 | 2014-04-08 | Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere |
| SG10202002556QA SG10202002556QA (en) | 2013-04-08 | 2014-04-08 | Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201508336TA SG11201508336TA (en) | 2013-04-08 | 2014-04-08 | Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10463685B2 (en) |
| EP (2) | EP3682888A1 (en) |
| JP (1) | JP6525956B2 (en) |
| KR (1) | KR20150143587A (en) |
| CN (2) | CN105338987A (en) |
| AU (1) | AU2014251093B2 (en) |
| BR (1) | BR112015025206A2 (en) |
| CA (1) | CA2907924C (en) |
| HK (1) | HK1219418A1 (en) |
| MX (1) | MX2015014159A (en) |
| NZ (1) | NZ713498A (en) |
| RU (1) | RU2713555C2 (en) |
| SG (2) | SG11201508336TA (en) |
| WO (1) | WO2014168947A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180036331A1 (en) * | 2016-03-24 | 2018-02-08 | The Board Of Regents Of The University Of Texas System | Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds |
| EP3463370A4 (en) * | 2016-05-27 | 2020-04-08 | The Board of Regents of The University of Texas System | 6-thio-2'-deoxyguanosine (6-thio-dg) results in telomerase dependent telomere dysfunction and cell death in therapy-resistant cancer cells |
| AU2019208197A1 (en) | 2018-07-31 | 2020-02-20 | Howmedica Osteonics Corp. | Fixation devices and prostheses for soft tissue connection to the same |
| AU2019360210A1 (en) * | 2018-10-17 | 2021-06-10 | Xibin Liao | 6-Mercaptopurine nucleoside analogues |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57209226A (en) | 1981-06-18 | 1982-12-22 | Yamasa Shoyu Co Ltd | Antitumor activity intensifier |
| EP0570519B1 (en) | 1991-02-08 | 1999-05-06 | Pro-Neuron, Inc. | Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| EP1879657A2 (en) | 2005-04-25 | 2008-01-23 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Use of compounds to enhance processivity of telomerase |
| CN101220071B (en) * | 2008-01-17 | 2011-04-06 | 南京长澳医药科技有限公司 | Stable 6-methoxy-2',3'-dideoxy guanine nucleoside, method for preparing the same and medicament composition containing the same |
| US20100323979A1 (en) | 2009-06-16 | 2010-12-23 | Weis-Amon Angelika B | Methods and compositions for inhibiting proliferation of aneuploid cells |
-
2014
- 2014-04-08 SG SG11201508336TA patent/SG11201508336TA/en unknown
- 2014-04-08 RU RU2015147555A patent/RU2713555C2/en active
- 2014-04-08 AU AU2014251093A patent/AU2014251093B2/en not_active Ceased
- 2014-04-08 JP JP2016507608A patent/JP6525956B2/en active Active
- 2014-04-08 BR BR112015025206A patent/BR112015025206A2/en not_active Application Discontinuation
- 2014-04-08 MX MX2015014159A patent/MX2015014159A/en unknown
- 2014-04-08 CN CN201480032692.6A patent/CN105338987A/en active Pending
- 2014-04-08 KR KR1020157031880A patent/KR20150143587A/en not_active Application Discontinuation
- 2014-04-08 CN CN201910445731.XA patent/CN110339203A/en active Pending
- 2014-04-08 SG SG10202002556QA patent/SG10202002556QA/en unknown
- 2014-04-08 WO PCT/US2014/033330 patent/WO2014168947A2/en active Application Filing
- 2014-04-08 CA CA2907924A patent/CA2907924C/en active Active
- 2014-04-08 NZ NZ713498A patent/NZ713498A/en not_active IP Right Cessation
- 2014-04-08 US US14/247,967 patent/US10463685B2/en active Active
- 2014-04-08 EP EP20155920.0A patent/EP3682888A1/en active Pending
- 2014-04-08 EP EP14726468.3A patent/EP2983675A2/en not_active Withdrawn
-
2016
- 2016-06-27 HK HK16107437.8A patent/HK1219418A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3682888A1 (en) | 2020-07-22 |
| US10463685B2 (en) | 2019-11-05 |
| EP2983675A2 (en) | 2016-02-17 |
| RU2713555C2 (en) | 2020-02-05 |
| CN105338987A (en) | 2016-02-17 |
| BR112015025206A2 (en) | 2017-07-18 |
| JP2016516773A (en) | 2016-06-09 |
| AU2014251093B2 (en) | 2017-06-15 |
| NZ732228A (en) | 2020-11-27 |
| NZ713498A (en) | 2017-07-28 |
| RU2015147555A (en) | 2017-05-15 |
| JP6525956B2 (en) | 2019-06-05 |
| SG11201508336TA (en) | 2015-11-27 |
| WO2014168947A3 (en) | 2015-02-19 |
| US20140303239A1 (en) | 2014-10-09 |
| CA2907924A1 (en) | 2014-10-16 |
| MX2015014159A (en) | 2016-06-21 |
| AU2014251093A1 (en) | 2015-10-15 |
| WO2014168947A9 (en) | 2014-12-31 |
| CN110339203A (en) | 2019-10-18 |
| HK1219418A1 (en) | 2017-04-07 |
| KR20150143587A (en) | 2015-12-23 |
| WO2014168947A2 (en) | 2014-10-16 |
| CA2907924C (en) | 2022-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20182097T1 (en) | Icebreaking vessel | |
| AU359765S (en) | Bus | |
| HK1220737A1 (en) | Measures of short telomere abundance | |
| GB2541833B (en) | Improvements to implant surfaces | |
| HK1219250A1 (en) | Fast pcr heating | |
| GB201309236D0 (en) | Delay adjustment | |
| ZA201702401B (en) | Composition with reduced immunogenicity | |
| EP2986719A4 (en) | Fusion polymerases | |
| GB2532042B (en) | Pure delay estimation | |
| IL248627A0 (en) | Amorphous form of apremilast | |
| IL239680B (en) | Compositions and methods for polynucleotide transferction | |
| HK1219418A1 (en) | Mercaptopurine ribonucleoside analogues for altering telomerase mediated telomere | |
| GB201715452D0 (en) | Coconut tap | |
| SG11201602845UA (en) | Pyrometer background elimination | |
| SI2868251T1 (en) | Dishwasher with start delay | |
| PT3485914T (en) | Telomerase reverse transcriptase-based therapies | |
| GB2538045B (en) | Improvements to letter-plates | |
| PT3176022T (en) | Bus | |
| IL240171A0 (en) | Crystalline form of linaclotide | |
| EP2977047A4 (en) | Nutrition composition | |
| TWM475361U (en) | Automatic locking type eraser | |
| GB201521028D0 (en) | Improvements to Li-fi | |
| AU2015316V (en) | SUPA2221 Argyranthemum frutescens | |
| TWM490369U (en) | Tapping structure | |
| AU362337S (en) | Coconut tap |